Dr. Mark S. Humayun, 2015 Presidential Honoree For Technological Innovation, Named Keynote Speaker For Envision Conference 2017

January 20, 2017
Wichita, Kan. – Envision announced today that Mark S. Humayun, MD, PhD, a Los Angeles-based ophthalmologist, engineer, professor, scientist and inventor who was named a 2015 recipient of the National Medal of Technology and Innovation by President Barack Obama, will deliver the keynote address at the 12th annual Envision Conference. The conference will take place July 26-29 at the Renaissance Phoenix Glendale Hotel & Spa in Glendale, Ariz., providing unprecedented opportunities for low vision professionals in multidisciplinary fields to exchange ideas and information. The 2017 event is made possible through the support of Visionary Sponsor, LC Industries in Durham, N.C.
 
Dr. Humayun has more than 100 patents and patent applications to his name and co-invented the Argus Series retina implant – a “bionic eye” manufactured by Second Sight that is intended to induce visual perception. Time Magazine named the implant among the top 10 inventions of 2013. His presentation at Envision Conference 2017 will discuss the genesis of the Argus II and address the importance of innovation in addressing vision loss.
 
“We are honored to have Mark Humayun as our keynote speaker,” said Michael Epp, manager of professional education at Envision. “Dr. Humayan’s groundbreaking work in biotechnology coupled with his commitment to education and his many awards, certifications and professional association memberships keep him active on the frontlines of vision research and care. We expect his address to be the catalyst to many fervent and fruitful discussions over the course of our four-day conference.”
 
Dr. Humayun is co-director of the University of Southern California (USC) Roski Eye Institute, director of the USC Institute for Biomedical Therapeutics, the Cornelius J. Pings Chair in Biomedical Sciences at the Keck School of Medicine of USC and a professor of ophthalmology, biomedical engineering, cell and neurobiology and director of sensory science initiatives at USC.
 
 
Envision Conference offers vision care professionals 90 hours of clinical education and research sessions and is the only multidisciplinary conference where ophthalmologists, optometrists, occupational therapists, rehabilitation therapists, vision researchers, nurses, special education teachers, government policy makers, assistive technology practitioners and suppliers and others can receive updates and collaborate on the latest advancements in low vision rehabilitation, research, practice and technology. Attendees can also view exhibits of the latest low vision products and services and share knowledge from around the globe in an effort to improve approaches to minimizing the adverse impact of vision loss.
 
As an added incentive, attendees can earn continuing education accreditation at many sessions through agencies including:
 
  • The Council on Optometric Practitioner Education (COPE);
  • Accreditation Council for Continuing Medical Education (ACCME);
  • American Occupational Therapy Association (AOTA);
  • Academy for Certification of Vision Rehabilitation & Education Professionals (ACVREP);
  • Commission on Paraoptometric Certification (CPC);
  • Commission on Rehabilitation Counselor Certification (CRCC); and
  • Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO).
 
Registration is now open and submissions are currently being accepted for prospective clinical education and research abstract presentations. Visit envisionconference.org for more details.
 
About Envision: Envision (www.envisionus.com) promotes advocacy and independence for those who are blind or low vision. Founded in 1933, Envision is one of the largest employers of individuals with vision loss in the nation. Headquartered in Wichita, Kan., Envision’s mission is to improve the quality of life and provide inspiration for the blind and visually impaired through employment, outreach, rehabilitation, education and research. For more information, visit www.envisionus.com
 

Latest news